Risek IV™

Risek IV™

Therapeutic Segment: Anti-Ulcerant

Generic Name: Omeprazole sodium

Indication:

For patients who are unable to take oral therapy for the short-term (upto 5 days) treatment of:

  • Gastro-oesophageal reflux disease.
  • Peptic ulcer disease.
  • Treatment and prophylaxis of NSAID-associated ulceration.
  • Duodenal ulcer.
  • Zollinger-Ellison syndrome.
  • Prophylaxis of acid aspiration.

Available as:

Injectable
  • 40MG